Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer

Fig. 1

IL20RB is highly expressed in tumor tissues of pancreatic cancer patients and is associated with poor prognosis. A Representative immunofluorescence images of IL20RB and pan-CK in human pancreatic cancer sections and surrounding tissues, scale bar = 40 µm. B Statistical analysis of IL20RB staining intensity in pancreatic cancer tissue sections from patients at different stages. C Correlation analysis between IL20RB staining intensity and overall survival of patients with pancreatic cancer, and the cut-off value was the median of IL20RB staining intensity. D IL20RB mRNA expression in pan-cancer and normal tissues, and the red arrow indicates pancreatic cancer, data from TCGA. E IL20RB mRNA expression in normal pancreatic tissues and pancreatic cancer tissues, data from TCGA. F mRNA expression of IL20RB in pancreatic cancer and paired adjacent tissues, data from Gene Expression Omnibus (GSE15471). G Correlation analysis of IL20RB mRNA expression level and overall survival of patients with pancreatic cancer, data from TIMER2.0 database. (H–K) Correlation analysis of IL20RB mRNA expression at T stage, N stage and AJCC stage and survival status of patients with pancreatic cancer, data from TCGA

Back to article page